Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/03009742.2021.1926318

PubMed Identifier: 34474634

Publication URI: http://europepmc.org/abstract/MED/34474634

Type: Journal Article/Review

Volume: 51

Parent Publication: Scandinavian journal of rheumatology

Issue: 2

ISSN: 0300-9742